Journey Medical Corporation (DERM) compared with its closest peers (NERV, RNA, IMUX, KROS, ANTX). Peer set by Business model: Biotech (Clinical / Commercial-Stage); 10 closest by market cap; US-domiciled. First-party data.
| Company | Market Cap | P/E |
|---|---|---|
| Minerva Neurosciences, Inc. (NERV) | $230.14M | -0.1 |
| Avidity Biosciences, Inc. (RNA) | $226.39M | -14.5 |
| Immunic, Inc. (IMUX) | $225.00M | -0.9 |
| Keros Therapeutics, Inc. (KROS) | $219.29M | 8.8 |
| AN2 Therapeutics, Inc. (ANTX) | $218.87M | -1.0 |
| SIGA Technologies, Inc. (SIGA) | $218.76M | 10.8 |
| PepGen Inc. (PEPG) | $216.78M | -3.1 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | $201.15M | -1.4 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | $200.38M | -1.1 |
| Oramed Pharmaceuticals Inc. (ORMP) | $199.67M | 3.9 |
| Sector P/E (Healthcare) | 21.7 |
| Industry P/E (Pharmaceutical Products) | 17.0 |
DERM overview · DERM earnings · DERM financials · DERM KPIs · DERM investor relations · DERM ownership · DERM filings
Data sourced from U.S. SEC EDGAR filings and market data. Not personalized investment advice.